Actively Recruiting
Safety and Feasibility Evaluation of the heepSync Algorithm for Electrical Stimulation of Respiratory Muscles in ICU Patients on Mechanical Ventilation
Led by Tesai Care SL · Updated on 2026-09-21
20
Participants Needed
3
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying ventilator-induced diaphragm dysfunction VIDD and weaning failure in ICU patients who require mechanical ventilation. The trial aims to evaluate the safety and early performance of a new device algorithm, called heepSync, designed to provide synchronized transcutaneous electrical stimulation of both inspiratory and expiratory respiratory muscles. This device seeks to offer a practical, non-invasive way to activate respiratory muscles during assisted breathing, addressing significant muscle atrophy seen in ventilated patients. Participants will use the Heecap device, which delivers electrical stimulation to respiratory muscles based on a novel synchronization algorithm. The study includes a single group of mechanically ventilated adult ICU patients who receive this device treatment. A small subset will test multifield electrodes compared to conventional ones to assess safety and feasibility. The treatment phase lasts up to 3 days, with monitoring continuing during this period. During the trial, participants will be closely monitored for device synchronization success and safety outcomes such as adverse events. Muscle function will be evaluated through measurements like transdiaphragmatic pressure, muscle thickening fraction, and occlusion pressure on treatment days 1 and 2. The study lasts up to 4 days, including assessment of safety and device performance, aiming to understand the feasibility of this stimulation approach in critical care settings.
CONDITIONS
Brief Title
Evaluation of heepSync, a Novel Algorithm for Transcutaneous Electrical Stimulation of Respiratory Muscles in Mechanically Ventilated Patients.
Research Team
B
Barbara Flix, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here